An overall burden of rare structural genomic variants has not been reported in bipolar disorder (BD), although there have been reports of cases with microduplication and microdeletion. Here, we present a genome-wide copy number variant (CNV) survey of 1001 cases and 1034 controls using the Affymetrix single nucleotide polymorphism (SNP) 6.0 SNP and CNV platform. Singleton deletions (deletions that appear only once in the dataset) more than 100 kb in length are present in 16.2% of BD cases in contrast to 12.3% of controls (permutation P = 0.007). This effect was more pronounced for age at onset of mania p18 years old. Our results strongly suggest that BD can result from the effects of multiple rare structural variants.
Introduction
Bipolar disorder (BD) is a chronic psychiatric disorder with a worldwide lifetime prevalence of 0.5-1.5% in the general population. 1 Twin, family and adoption studies provide evidence of genetic predisposition for BD. 2, 3 Although BD is highly heritable, genome-wide association approaches have yielded limited findings. [4] [5] [6] Rare copy number variants (CNVs, small segmental duplications and deletions), have recently produced encouraging and exciting results for autism and schizophrenia. [7] [8] [9] [10] [11] [12] De novo CNVs affecting many loci were identified in 10% or more of sporadic autism patients. 7 Walsh et al. 10 found that the proportion of individuals with schizophrenia who carry novel structure variants in schizophrenia was significantly higher than controls. Rare deletions and duplications or large recurrent deletions increased the risk of schizophrenia in two other reports. 8, 9 Both family and genetic studies of BD and schizophrenia suggest shared genetic susceptibility, 13 so it is reasonable to search for association of CNVs with BD.
Systematic genome-wide CNV analysis with BD has not yet been reported. We attempted to identify rare CNVs in people with BD using a single nucleotide polymorphism (SNP)-and CNV probe-based platform (Affymetrix SNP 6.0), as part of Genetic Association Information Network (GAIN) project. Our primary hypothesis is that individuals with BD would have a greater genome-wide burden of rare CNVs (either deletions or duplications). Singletons are CNV events that occur once in a dataset. In our sample size (1001 patients and 1033 controls) the overall frequency of singletons is roughly comparable to the rare CNVs reported to be increased in disease (up to six deletion or duplication events) in the International Schizophrenia Consortium's study (3391 cases and 3181 controls). 9 This led us to focus on singleton events in our analysis (see below).
Materials and methods

Sample recruitment
The study population and subject characteristics are described elsewhere.
14 In brief, this is a genome-wide association case-control study including a European American sample of 1001 bipolar cases and 1033 controls. The patients were recruited at 11 data collection sites. Patients were interviewed with the Diagnostic Interview for Genetic Studies, 15 medical records were obtained and final diagnosis was based on the current APA Diagnostic and Statistical Manual, 4th edition. 16 Control samples were ascertained separately through a volunteer panel and a web-based psychiatric interview, by a grant awarded Dr Pablo Gejman and collaborators by the National Institutes of Mental Health (NIMH).
Genotype and CNV detection
Genotyping was carried out by the Broad Institute Center for Genotyping and Analysis (http:// www.broad. mit.edu/node/306), as part of a genomewide association study (GWAS) of BD, with the support of the GAIN. 17 The Affymetrix SNP 6.0 array, which was employed, includes 906 600 SNP and 940 000 copy number probes. 18 Of the CNV probes, 800 000 are evenly spaced along the genome, whereas the rest are targeted to 3700 known CNV regions.
The Affymetrix Power Tool (APT-1.10.0, plug-in to Birdsuite 1.5.2) was used to do platewise normalization. CNVs were identified using Birdsuite (version 1.5.2; http://www.broad.mit.edu/mpg/birdsuite/ analysis.html), which integrates different methods for calling CNVs. Known common CNVs are called with the Canary program, which behaves in a similar way to SNP genotyping, using existing information about known CNVs to train clustering algorithms and assign a prior probability of aberrant copy number to guide interpretation of measurements. 19 The Birdseye program was used to discover rare or de novo CNVs, based on a hidden Markov model; 19 for each CNV a logarithm of the odds ratio (LOD) score was generated that describes the likelihood of a CNV relative to no CNV over a given interval including flanking sequences. Global tests of CNV burden in cases vs controls, and association testing of common CNVs, were performed by PLINK (version 1.04, http://pngu.mgh.harvard.edu/purcell/plink/). 20 Quality control Quality control (QC) was performed on SNPs to remove duplicate samples, poorly genotyped and/or contaminated samples and poorly performing SNPs, as part of standard QC measures used for the wholegenome association study of the same sample. 14 The genotype data are available through database of genotype and phenotype (phs000017.v1.p1).
For 2034 individuals passing QC, we observed 535 553 regions with a copy number other than 2 in autosomes and chromosome X. Chromosome Y was removed from the analysis as the Y chromosome is apparently incorrectly segmented by Birdsuite, version 1.5.2.
To generate results with high confidence, we included only CNVs with a physical length greater than 100 kb and LOD score X10. A total of 53 951 segments with a frequency X10% were identified. We removed outliers based on numbers of frequent CNVs per individual or per chromosome. A total of 51 chromosomes with abnormal CNV estimates were removed (autosomes or chromosome X of women with more than 2.25 copies or less than 1.75 copies and chromosome X of men with more than 1.2 copies or less than 0.8 copy). We also removed individuals with more than 65 common segments, leaving 51 757 common segments.
For rare CNVs, three individuals were overrepresented ( > 10 segments with a frequency < 1%). In addition, based on permutation of the frequency of multiple singleton events per individual (from the overall frequency of these events) we excluded 2 individuals with more than five singleton deletions and 4 individuals with more than five singleton duplications, leaving 1999 individuals (998 cases and 1001 controls, 997 women and 1002 men). These exclusions left 2311 rare CNVs to be analyzed. Among unique, nonoverlapping CNVs, there were 310 singleton deletions and 480 singleton duplications.
Plate effects
There were 41 96-well plates in the dataset. We tested for plate effects in common CNVs (frequency X10%), by doing a series of GWASs of CNVs by plate. We compared the CNV frequency measured for each plate against that of all other plates in each analysis, using PLINK. As there were 41 plates, there were 41 tests. The a for each GWAS is 0.05, so we would expect approximately two positive results by chance.
A similar analysis of plate effect for common CNVs revealed that 560 position markers, from chr8, chr15, chr21 and chr22, showed a plate effect with an EMP2 P-value p0.05 (familywise P-value across all markers in an analysis), which is many times the expected number and constitutes evidence that there is a plate effect in the common CNV data.
We also did a burden test for plate effects for rare CNVs (frequency < 1%, more than 100 kb in length and LOD score > 10). None of the plates showed a significantly higher number of segments per person (RATE) than all others and none of the plates showed a significantly higher proportion of individuals (PROP) with one or more segments (data not shown).
Quantitative real-time PCR
We performed quantitative real-time PCR (qPCR) using SYBR-green dye to measure the copy number of singletons. HOXA7 was used as an endogenous control. For each region we designed three pairs of primers and tested five samples (one with a putative deletion/duplication, the other four with putative two copies). As the threshold cycle number (Ct) is a function of the amount of starting template, 21 
Pathway analysis
We compared genes disrupted in cases vs those disrupted (included in or partially overlapped with the CNVs) in controls using Ingenuity Pathways Analysis (IPA; Ingenuity Systems, Redwood City, CA, USA, www.ingenuity.com). Genes associated with in the Ingenuity Pathways Knowledge Base were considered for the analysis. Ingenuity uses Fischer's exact test to calculate a P-value determining the probability that each pathway assigned to that dataset is because of chance alone.
Results
Singleton deletions increased in BD vs controls
The number of singleton deletions per person was significantly enriched in cases vs controls (0. 176 vs 0.134, P-value = 0.010; Table 1 ). The proportion of cases with at least one singleton deletion was significantly higher than the proportion of controls (16.2 vs 12.3%, P-value = 0.007). The locations and phenotypes of the singleton deletions in this study are in Supplementary Table 2 . The number of genes disrupted by singleton deletions did not differ between cases and controls (234 genes in cases and 206 genes in controls, P-value = 0.21).
For singleton duplications, no difference was observed between cases and controls. The proportion of cases with at least one singleton duplication was nominally higher than controls (0.324 vs 0.290, P-value = 0.054).
For slightly more frequent rare CNVs (2-6 in dataset of B2000 individuals), there were no significant differences between cases and controls (data not shown).
Singleton deletions more frequent in earlier onset BD Considering only patients with onset of mania at age not older than 18 years, the number of segments per person increased from 0.176 to 0.203. The proportion of individuals with at least one singleton deletion increased from 0.162 to 0.189. Considering singleton deletions and duplications together, there was a significant case-control difference in the proportion of individuals with singleton CNVs (P-value = 0.039). The proportion of earlier onset individuals with at least one singleton deletion is marginally higher than that in later onset patients (Table 2 ; P-value = 0.05).
Genes and pathways impacted by singleton deletions
Genes disrupted by CNVs in our cases were significantly overrepresented in pathways categorized by Ingenuity as important for psychological disorders and behaviors like learning (Table 3 ; P-value = 6.30EÀ06 and 8.29EÀ03, respectively). Four singleton deletion regions overlapped with the novel deletions/duplications that were identified in children but not parents in Walsh et al. 10 Two genes affected by CNVs in this study (GRM7, LARGE) were also in the disrupted gene list in the Walsh et al. 10 study. No such category was found overrepresented in controls. These overlapping genes could conceivably be involved in risk for both BD and schizophrenia. Abbreviations: PROP, proportion of sample with one or more segments; RATE, number of segments per person. P-value presented: difference between groups based on 10 000 permutations. For each region, the copy number was calculated as the mean of 2
ÀDDCt of three pairs of primers. The results of reverse transcriptase-PCR for one singleton deletion and one singleton duplication are graphically displayed in Supplementary Figure 1 , as an example.
Specific CNV associations
Three specific regions (15q13.3, 22q11.2, 1q21.1) have been repeatedly reported to contain rare deletions associated with schizophrenia. 8, 9, 23 In our own data, because of overlap or proximity to regions with plate effects, we were unable to test these regions for association.
Discussion
The rarest CNVs are interesting because they are presumably enriched in de novo events. Under a rare variant hypothesis of common diseases, where multiple rare variants with high effect sizes would, in aggregate, make a substantial contribution to illness, these would be a prime type of variant to study because they have not yet been subject to selection. There have been several recent studies supporting a very rare variants hypothesis for schizophrenia and autism. [7] [8] [9] [10] [11] [12] In the current data, singleton deletions showed a 1.31-fold increase in BD. BD cases (16.2%) possessed at least one singleton deletion, in contrast to 12.3% of controls. Singleton deletions were significantly enriched in BD individuals, unlike slightly more frequent rare CNVs (2-6 occurrences). These data suggest that the burden of very rare (occurring in under 1/2000 individuals) de novo deletions increases risk of BD.
Considering the sample size of this study, our burden corresponds to the increased singleton and rare deletion (2-6 events) frequencies in schizophrenia and autism reported in much larger samples in recent publications. 8, 9, 11 It is interesting that we observe a marginally greater overall burden in BD with earlier age at onset of mania. Among these cases, 18.9% possessed at least one singleton deletion. In contrast, 14.7% of BD cases with older onset carried at least one singleton deletion. We would speculate that early onset BD might be more severe and more likely to be caused by de novo mutations.
Genes disrupted by singleton deletion CNVs in our cases were significantly overrepresented in IPA for psychological disorders and learning behaviors, even though the pathways assembled in IPA may not form a one true biological pathway. One gene (GRM7) was implicated in two prior BD GWAS studies. 4, 6 Sixteen genes partially or wholly included in CNVs in this study, including CNTNAP2, COMT and GNB1L, are included in the IPA psychological disorders pathway. Genomic deletions of the CNTNAP2 locus in chromosome 7 were found in three patients with schizophrenia. 24 Catechol-O-methyltransferase regulates dopamine levels in the brain and has long been proposed to be involved in the development of schizophrenia.
25 GNB1L is located in the chr22q11.2 susceptibility region for schizophrenia, and may be associated with BD. 26 Two genes (GRM7, LARGE) were also among the list of disrupted genes in the Walsh et al. 10 study. There is evidence that BD and schizophrenia share genetic susceptibility, and the current data suggest they share some rare CNV regions.
We have found suggestive evidence that individuals with BD have a greater burden than controls of singleton deletions across their genomes, which is even greater among patients with earlier onset of mania. Taken together, these singleton findings could account for an appreciable fraction of susceptibility to BD, as the excess frequency of singleton deletions in BD vs controls is close to 4%.
